ABSTRACT
Objective Face masks also referred to as half masks are essential to protect healthcare professionals, working in close contact with patients having Covid-19 related symptoms. During the threating deficit, healthcare institutions sought an approach to re-use face masks or to acquire imported masks. The objective of this study is to assess the quality of sterilised and imported FFP2/KN95 face mask materials.
Design prospective, bench-to-bedside
Setting General healthcare including 19 hospitals in the Netherlands
Interventions Face masks were reprocessed using a medical autoclave at 121°C.
Methods A 48 minutes steam sterilization process of single-use face masks with 15 min holding time at a 121 °C was developed, validated and implemented in 19 different hospitals. Steam and H2O2 plasma sterilized as well as new, imported masks are tested in a custom-made, non-standard EN-149, test set-up that measures Particle Filtration Efficiency (PFE) and pressure drops.
Results PFE validation data of 84 masks indicated differences of 2.3±2 % (mean±SD) between the custom build test set-up and a continues flow according to the EN-149. Test data showed the mean PFE values of 444 sterilised FFP2 face masks from 19 CSSD were 90±11% (mean±SD) and of 474 imported KN95/FFP2 face masks 83±16% (mean±SD). Differences in PFE between sterilisation departments were found.
Conclusion Face masks can be reprocessed with 121 0 C steam or H2O2 plasma sterilization with minimum reduction of PFE. PFE comparison between sterilised mask and new, imported mask filter material indicates that most reprocessed masks of high quality brands outperform new imported face masks of unknown brands. Although the PFE of tested face mask material from different sterilisation departments remained efficient, different types of sterilisation equipment can result in different PFE outcomes.
Strengths and limitations of this study
– Reprocessing face masks at 121 °C steam Sterilization, a simple method to be used by hospitals in times of shortages
– Laboratory findings to evaluate the safety and quality of face mask material
– The study is limited and restricted to selected FFP-2 face masks
– This study is a first of its kind in quality and safety check of the vast growing face masks, entering our markets
– The study focusses on testing environmental dry particles in a rapid test setup
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding statement The cooperative Rabobank Zuid-Holland Midden supported the initiative with a financial gift from their noodfonds.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All ethical guidelines have been followed
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.